Leadership
The Kannalife leadership team has more than 40 years of business, marketing and drug development experience with Fortune 500, Pharma and leading Biotechnology firms. Our scientific team, Board of Directors and Scientific Advisory Board are comprised of dedicated business professionals, clinicians and bio-chemists, all have a strong background in phyto-medical, biological and pharmaceutical sciences with a long track record of successful drug development and identifying phyto-medicine and therapeutics that are complex in nature and structure. Overall, the Kannalife scientific team has over 75+ years of research and pharmaceutical experience and have been published in over 300 notable journal publications and jointly hold over 65 patents.
Executive Team

Dean Petkanas
Chairman & CEO

William A. Kinney, PhD
Chief Scientific Officer

Thoma Kikis
Founder / Chief Communications Officer, Board Director

Mark Corrao
Chief Financial Officer

Douglas Brenneman, PhD
Chief Pharmacologist

Mark McDonnell, PhD
Chief Chemist
Board of Directors

Dean Petkanas
Chairman & CEO

Thoma Kikis
Founder / Chief Communications Officer, Board Director

Robert Malasek
Director

Blake Schroeder
Board Director

Timothy Scott, PhD
Board Director
Scientific Advisory Board

Tage Honoré, Phd, DSc
Chairman of Scientific Advisory Board

Daniele Piomelli, PhD, MD
Scientific Advisory Board

Charles L. Loprinzi, MD
Scientific Advisory Board

Michael Ropacki, PhD
Scientific Advisory Board

Daniel Richman, MD
Scientific Advisory Board

Terrence O. Tormey
Company Advisory Board
